Key publications
All Publications
- van Dussen L., Lips P., Everts V. E., Bravenboer N., Jansen I. D. C., Groener J. E. M., Maas M., Blokland J. A. K., Aerts J. M. F. G., Hollak C. E. M. Markers of bone turnover in Gaucher disease: modeling the evolution of bone disease Journal of clinical endocrinology and metabolism 2011;96 (7):2194-2205 [PubMed]
- van Dussen Laura, Biegstraaten Marieke, Hollak Carla E. M., Dijkgraaf Marcel G. W. Cost-effectiveness of enzyme replacement therapy for type 1 Gaucher disease Orphanet journal of rare diseases 2014;9 (1):51 [PubMed]
- van Dussen Laura, Biegstraaten Marieke, Dijkgraaf Marcel Gw, Hollak Carla Em Modelling Gaucher disease progression: long-term enzyme replacement therapy reduces the incidence of splenectomy and bone complications Orphanet journal of rare diseases 2014;9 (1):112 [PubMed]
- van Dussen L., Hendriks E. J., Groener J. E. M., Boot R. G., Hollak C. E. M., Aerts J. M. F. G. Value of plasma chitotriosidase to assess non-neuronopathic Gaucher disease severity and progression in the era of enzyme replacement therapy Journal of inherited metabolic disease 2014;37 (6):991-1001 [PubMed]
- van Dussen L., Akkerman E. M., Hollak C. E. M., Nederveen A. J., Maas M. Evaluation of an imaging biomarker, Dixon quantitative chemical shift imaging, in Gaucher disease: lessons learned Journal of inherited metabolic disease 2014;37 (6):1003-1011 [PubMed]
Research programmes
Prof. PhD C.E.M. Hollak (Natural history, pathophysiology and treatment of lysosomal storage disorders and regulatory science of orphan drugs)
(Medewerkers buiten research programmes van afdeling Inwendige Geneeskunde: Endocrinologie)